Obicetrapib lowers LDL-C in patients on high intensity statins: Results from the rose trial (NCT04753606). (August 2022)

Record Type:: Journal Article
Title:: Obicetrapib lowers LDL-C in patients on high intensity statins: Results from the rose trial (NCT04753606). (August 2022)
Main Title:: Obicetrapib lowers LDL-C in patients on high intensity statins: Results from the rose trial (NCT04753606)
Authors:: Ray, K.K.
Nicholls, S.
Ditmarsch, M.
Kastelein, J.J.
Rigby, S.
Kling, D.
Curcio, D.
Alp, N.
Davidson, M.
Abstract:
Is Part Of:: Atherosclerosis. Volume 355(2022)
Journal:: Atherosclerosis
Issue:: Volume 355(2022)
Issue Display:: Volume 355, Issue 2022 (2022)
Year:: 2022
Volume:: 355
Issue:: 2022
Issue Sort Value:: 2022-0355-2022-0000
Page Start:: 11
Page End:: 12
Publication Date:: 2022-08
Subjects:: Arteriosclerosis -- Periodicals
Electronic journals
616.136
Journal URLs:: http://www.sciencedirect.com/science/journal/00219150 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00219150 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.atherosclerosis.2022.06.033 ↗
Languages:: English
ISSNs:: 0021-9150
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1765.874000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 23300.xml